AstraZeneca Gets CDSCO Panel nod to study Anti-cancer Drug Datopotamab Deruxtecan and Durvalumab Dr. Divya Colin23 Feb 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee SEC functional under the Central Drug Standard Control...
CDSCO Panel grants Cipla's Prescribing Information update for Bovine Lipid Extract Surfactant Suspension Dr. Divya Colin22 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Introduces Online Application System to issue Neutral Code for manufacturing Medical Devices for export Dr. Divya Colin21 Feb 2024 6:00 PM ISTNew Delhi: With an aim to streamline the regulatory submission procedure, and to enhance efficiency and facilitate smoother regulatory procedures, the...
Indian Pharmaceutical Market soars with 9.5% growth in January 2024: Pharmarack Report Farhat Nasim20 Feb 2024 5:56 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) exhibited a robust growth of 9.5% in terms of value and 2.07% in units, reaching a total value of...
Indian Pharma Market registers 8 percent surge to Rs 17,937 Crore in January 2024: IQVIA Farhat Nasim19 Feb 2024 7:19 PM ISTNew Delhi: In an impressive kickoff to 2024, the Indian pharmaceutical market surged by 8%, reaching a substantial Rs 17,937 crore in January, as per...
CDSCO releases regulatory guidelines for sampling of drugs, cosmetics and medical devices Ruchika Sharma19 Feb 2024 6:30 PM ISTNew Delhi: In order to streamline and rationalize the sampling procedure of drugs, cosmetics and medical devices and maintaining a centralized monthly...
CDSCO Panel Rejects Dr Reddy's Proposal to Study FDC of Ketorolac plus Serratiopeptidase Capsules Dr. Divya Colin18 Feb 2024 6:00 PM ISTNew Delhi: Citing there is no rationality of the combination and significant benefits, the Subject Expert Committee (SEC) functional under the...
By Doctors' Prescription only: Oseltamivir and Zanamivir added into Schedule H1 Drugs Dr. Divya Colin17 Feb 2024 6:00 PM ISTNew Delhi: Through a recent gazette notification, the Ministry of Health and Family Welfare, Government of India, has placed Oseltamivir and Zanamivir...
Sun Pharma Gets CDSCO Panel Nod to Study Tildrakizumab Injection 100 mg/ ml Dr. Divya Colin16 Feb 2024 6:00 PM ISTNew Delhi: The drug major Sun Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AIOCD asks Mankind Pharma to take down HealthOk ad endorsed by Ranvir Singh, calls it misleading Farhat Nasim15 Feb 2024 3:58 PM ISTNew Delhi: The All India Organisation of Chemists and Druggists (AIOCD) has called for the removal of an advertisement featuring actor Ranveer...
Submit Safety Data From Phase I CT : CDSCO Panel Tells Novo Nordisk on CagriSema Dr. Divya Colin14 Feb 2024 6:00 PM ISTNew Delhi: Reviewing the Phase II clinical study protocol of CagriSema, a combination medication that includes semaglutide and Cagrilintide, the...
Akums Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Drug Dr. Divya Colin13 Feb 2024 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
